Ono and Seikagaku Submit a New Drug Application for Manufacturing and Marketing Approval for ONO-5704/SI-613 for the Treatment of Osteoarthritis in Japan
Ono and Seikagaku Submit a New Drug Application for Manufacturing and Marketing Approval for ONO-5704/SI-613 for the Treatment of Osteoarthritis in Japan
01.06.2020
This link will direct you to a third-party site.(Another window opens.)
The Seikagaku Corporation website uses cookies to personalize contents and offer a better browsing experience. Please click the Accept botton. (Read more)